| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 07/09/2008 | EP1594853B1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof |
| 07/09/2008 | CN101215244A Method for synthesizing 5-amino-2,4,6-triiodoisophthaloyl dichloride |
| 07/09/2008 | CN101215243A Method for preparing aceclofenac |
| 07/09/2008 | CN101215242A Technique for synthesizing aceclofenac benzyl ester |
| 07/09/2008 | CN100400513C Phenylalanine enamide derivatives |
| 07/09/2008 | CN100400503C 5,5,5 trifluorin 4 (4 methox phenyl amido) methyl valerate, and synthetic method |
| 07/09/2008 | CN100400502C Process for the preparation of highly concentrated flowable aqueous solutions of betaines |
| 07/09/2008 | CN100400497C Compounds of class of styracin and cinepazid ester phenylpropionic acid, prepration method and application |
| 07/08/2008 | US7396898 Diamine, acid dianhydride, and reactive group containing polyimide composition prepared therefrom and process of preparing them |
| 07/08/2008 | CA2286631C Solid compositions suitable for oral administration comprising l-carnitine or an alkanoyl-l-carnitinecholine tartrate |
| 07/08/2008 | CA2285550C Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate |
| 07/08/2008 | CA2285380C Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-amino-ethanesulfonic acid |
| 07/08/2008 | CA2211939C Process for producing rhein and diacerhein |
| 07/03/2008 | WO2008079387A1 Catechol protected levodopa diester prodrugs, compositions, and methods of use |
| 07/03/2008 | WO2008077897A1 New products for the treatment of the iron chlorosis |
| 07/03/2008 | WO2007147222A3 Novel ionic liquids |
| 07/03/2008 | US20080161399 Agent for reduction of oxidized albumin level |
| 07/03/2008 | US20080161395 Derivatives of Aminobutanoic Acid Inhibiting Cpt |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080159954 Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use |
| 07/03/2008 | CA2672727A1 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 07/02/2008 | EP1939170A1 Process for the preparation of gabapentin hydrochloride |
| 07/02/2008 | EP1939157A1 New products for the treatment of the iron chlorosis |
| 07/02/2008 | EP1937243A2 Naphthyl derivatives as inhibitors of beta-amyloid aggregation |
| 07/02/2008 | EP1937063A1 Compounds and relative use for the control of phytopathogens |
| 07/02/2008 | EP1692127B1 Triphenylethylene compounds as selective estrogen receptor modulators |
| 07/02/2008 | CN101213193A Mono-lysine salts of azole compounds |
| 07/02/2008 | CN101209975A Levulorotation carnitine calcium fumarate and its preparing method and use |
| 07/02/2008 | CN101209974A Hydroxamic acids derivatives and use thereof |
| 07/02/2008 | CN100398513C Preparation of gabapendin |
| 07/01/2008 | USRE40418 Treatment of neoplasms with CCI-779/EKB-569 combination |
| 07/01/2008 | US7393974 Process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid |
| 07/01/2008 | US7393972 Process for preparing amino acid esters and their acid addition salts |
| 07/01/2008 | US7393967 reactants are more environmentally friendly, safe, less toxic to handle; reacion of 3-bromotrifluorotoluene with an allyl amine then reduction to give cinacalcet |
| 06/26/2008 | WO2008076707A2 Triamine/aspartate curative and coatings comprising the same |
| 06/26/2008 | WO2008076458A1 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
| 06/26/2008 | WO2008074154A1 Polymers comprising zwitterionic endgroups |
| 06/26/2008 | WO2008048121A3 Macrocyclic cysteine protease inhibitors and compositions thereof |
| 06/26/2008 | US20080154059 Reacting a cyclohexanecarboxylic acid derivative with an alkylating agent to form 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid; intermediate in the preparation of pharmaceutical active compounds |
| 06/26/2008 | US20080154058 Formation of oxime-containing compounds from reaction of carbonyl, hydroxylamine and bifunctional aromatic amines; incorporated into growth hormone |
| 06/26/2008 | US20080153889 Derivatives of 11-nonyloxy-undec-8(Z)-eonic acid, e.g., (Z)- 6-amino-2-(11-(nonyloxy)undec-8-enamido)hexanoic acid; compounds mimic epoxide metabolites; for use in treatment of renal or cardiovascular disease; hypotensive agents |
| 06/26/2008 | US20080153850 Adamantyl Derivates as P2x7 Receptor Antagonists |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080152603 Antioxidants |
| 06/26/2008 | CA2673336A1 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
| 06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
| 06/25/2008 | EP1193253B1 Process for producing optically active azetidine-2-carboxylic acids |
| 06/25/2008 | CN101208406A Synthesis of phenyl-substituted polyfluoroanthenes and the use thereof |
| 06/25/2008 | CN101205193A Salt compound formed by aceclofenac and organic base as well as composition and uses thereof |
| 06/24/2008 | US7390922 Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use |
| 06/24/2008 | US7390909 Processes of producing glutamic acid compounds and production intermediates therefore and novel intermediate for the processes |
| 06/24/2008 | US7390513 Theobromine, L-phenylalanine, nicotinamide adenine dinucleotide, cayenne pepper, and green tea; human dietary supplement to increase energy; nutraceuticals |
| 06/19/2008 | US20080146663 Derivatives of 11-nonyloxy-undec-8(Z)-eonic acid, e.g., (Z)-1,3-dihydroxypropan-2-yl 11-(nonyloxy)undec-8-enoate; compounds mimic epoxide metabolites; for use in treatment of renal or cardiovascular disease; hypotensive agents |
| 06/19/2008 | US20080146632 Fc Receptor Modulating Compounds and Compositions |
| 06/19/2008 | US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof |
| 06/19/2008 | US20080146509 delivery agent, parathyroid hormone, and calcitonin. This composition exhibits increased delivery of parathyroid hormone and/or calcitonin and is useful for the treatment of osteoporosis. The composition also permits simultaneous oral delivery of parathyroid hormone and calcitonin |
| 06/19/2008 | US20080145413 Lipids and lipid assemblies comprising transfection enhancer elements |
| 06/18/2008 | EP1932824A1 Method for synthesis of keto acid or amino acid by hydration of acethylene compound |
| 06/18/2008 | EP1931619A2 Process for esterification of an organic acid |
| 06/18/2008 | EP1931215A1 Feedstuff additive containing l-lysine |
| 06/18/2008 | EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 06/18/2008 | EP1513803B1 Ligands that are inhibitors of the rar receptors |
| 06/18/2008 | CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 06/18/2008 | CN100395230C Method for preparing high-purity gahapentin |
| 06/17/2008 | US7388031 Reacting an epoxy compound with a aminocylcohexane-phenyl derivative; useful as anti-obesity, anti-diabetic, cicatrizing and tocolytic medicinal products |
| 06/17/2008 | US7388023 Amino acids with affinity for the α2δ-protein |
| 06/17/2008 | CA2444053C Fused bicyclic or tricyclic amino acids |
| 06/12/2008 | WO2008067710A1 Substituted cyclohexane compounds, preparation methods and medicine uses thereof |
| 06/12/2008 | WO2008067709A1 Substituted cyclobutane compounds, preparation methods and pharmaceutical uses thereof |
| 06/12/2008 | US20080139842 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid; exocrine disease including parotitis, sialoadenitis, dacryoadenitis, dry eye syndrome, xerostomia, hidradenitis, and pancreatitis, or an endocrine disease including hypothyroidism, hypothalamus hypophysitis |
| 06/12/2008 | US20080139505 Potentiators Of Glutamate Receptors |
| 06/12/2008 | US20080138281 with C11 or F18 radioisotops; e.g. O-[18F]Fluoromethyl-L-tyrosine or O-[11C]methyl-L-tyrosine; comparison of the radiation dose of each tissue |
| 06/11/2008 | EP1930315A1 Process for production of mono-substituted alkylated compound using aldimine or derivative thereof |
| 06/11/2008 | CN101195573A Manufacture of esters |
| 06/11/2008 | CN101195570A Salt amino acid of ferulic acid |
| 06/10/2008 | US7385080 Method for producing optically active β-phenylalanine compounds |
| 06/10/2008 | US7385077 Fluoroalkyl surfactants |
| 06/10/2008 | US7384979 Substituted amino acids as erythropoietin mimetics |
| 06/10/2008 | US7384789 Divalent metal ion sensors and binders |
| 06/10/2008 | CA2288287C Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate |
| 06/05/2008 | WO2008065109A1 Process to prepare amino acid-n, n-diacetic acid compounds |
| 06/05/2008 | US20080132622 Electronic devices made with crosslinkable compounds and copolymers |
| 06/05/2008 | US20080132579 characterized by at least one of an enantiomeric excess of at least about 99.8%; having less than about 1700 ppm of residual C1-C4 alcohol; or having a pH of at least about 4.3 in 1% aqueous solution at room temperature |
| 06/05/2008 | US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis |
| 06/05/2008 | US20080132570 Levodopa prodrugs, and compositions and uses thereof |
| 06/05/2008 | CA2671022A1 Process to prepare amino acid-n, n-diacetic acid compounds |
| 06/05/2008 | CA2670736A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 06/04/2008 | EP1927588A2 Process for producing optically active azetidine-2-carboxylic acids |
| 06/04/2008 | EP1927586A1 Process for producing 5-aminolevulinic acid hydrochloride |
| 06/04/2008 | EP1927584A1 Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier |
| 06/04/2008 | EP1373268B1 Method for the manufacture of anagrelide |
| 06/04/2008 | CN101193852A Analogs of 4-hydroxyisoleucine and uses thereof |
| 06/04/2008 | CN100391934C Method for preparing L-glutamic acid |
| 06/03/2008 | US7381835 Resolution of racemic mixtures using an amine |
| 06/03/2008 | US7381831 Dimeric azo acetoacetamido dyes, e.g., Dimer Dianthranilate Bis-(2-ethylhexylacetoacetamide) Azo; for use in hot melt or phase change inks |
| 06/03/2008 | US7381748 Compounds and related methods for inhibition of gamma-aminobutyric acid aminotransferase |
| 06/03/2008 | US7381747 3-Aminomethyl-5-methyl-octanoic acid; antidepressant and anxiolytic agent; obsessive compulsive disorder (OCD), agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia; not addictive |
| 06/03/2008 | CA2350473C Method for producing optically active .alpha.-aminonitriles and .alpha.-amino acids |
| 06/03/2008 | CA2334579C Secondary aspartic acid amide esters |
| 06/03/2008 | CA2285552C Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |